Externally Funded Projects

  • KNEP: Norwegian Cancer Society (CS Verbeke: project leader)
  • PANCAIM: EU, project 101016851 (CS Verbeke)
  • Heterogeneity in pancreatic cancer: Kreftforeningen 2020-2025 (CS Verbeke)
  • Effect of neoadjuvant treatment on pancreatic cancer: Helse Sør-Øst 2018-2021 (CS Verbeke)
  • Metabolic rewiring and chemoresistance in pancreatic cancer: Helse Sør-Øst 2019-2022, Family Blix Endowment, and Fondsstiftelsen at Oslo University Hospital (M Amrutkar, CS Verbeke)
  • Tumor heterogeneity in pancreatic cancer: transcriptional subclassification and tumor metabolism: Den Norske Patologforening (MB Holm)
 
Page visits: 1585